Condition
Hereditary Diffuse Gastric Cancer
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed3
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04253106Not ApplicableCompletedPrimary
Liquid Biopsies for the Personalized Management of Patients with Hereditary Diffuse Gastric Cancer
NCT06163365Unknown
Inherited Cancer Early Diagnosis (ICED) Study
NCT03950908Not ApplicableCompletedPrimary
Biopsy Technique for Endoscopic Surveillance of Hereditary Diffuse Gastric Cancer
NCT00633607Completed
Hereditary Colorectal and Associated Tumor Registry Study
Showing all 4 trials